Rebus Holdings, Inc.
Rebus Holdings, Inc.
Your view on RBSH
Overview
What the company does, where it operates, and who runs it.
About Rebus Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Raul Silvestre
- Headquarters
- 2629 Townsgate Road, Westlake Village, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Raul Silvestre
- Headquarters
- 2629 Townsgate Road, Westlake Village, CA, US
Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.